Vivos Therapeutics (VVOS) Operating Income (2020 - 2026)
Vivos Therapeutics (VVOS) reported Operating Income of -$6.6 million for Q1 2026, down 68.84% year-over-year from -$21.2 million in Q1 2025, and down 3.65% quarter-over-quarter from -$6.4 million in Q4 2025.
Vivos Therapeutics (VVOS) Operating Income (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Operating Income data on file, last reported at -$6.6 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$6.6 million, down 68.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.6 million (down 99.88% YoY), and the FY2025 annual result was -$19.9 million, down 78.09% from the prior year.
- Operating Income fell to -$6.6 million in Q1 2026 per VVOS's latest filing, from -$6.4 million in the prior quarter.
- Over five years, Operating Income peaked at -$1.9 million in Q2 2024 and troughed at -$7.0 million in Q2 2022.
- A 5-year average of -$4.7 million and a median of -$4.7 million in 2025 frame the typical range for Operating Income.
- The sharpest annual moves came in 2022 and 2024: Operating Income plunged 169.61% in 2022, then jumped 57.14% in 2024.
- A 5-year view of Operating Income shows it stood at -$6.1 million in 2022, then jumped by 31.83% to -$4.1 million in 2023, then soared by 32.11% to -$2.8 million in 2024, then slumped by 127.44% to -$6.4 million in 2025, then retreated by 3.65% to -$6.6 million in 2026.
- Business Quant data shows VVOS's Operating Income at -$6.6 million in Q1 2026, -$6.4 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | -6.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.62 Mn |
| Dec 31, 2025 | -6.38 Mn |
| Sep 30, 2025 | -4.73 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -2.81 Mn |
| Sep 30, 2024 | -2.65 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -3.79 Mn |
| Dec 31, 2023 | -4.13 Mn |
| Sep 30, 2023 | -3.64 Mn |
| Jun 30, 2023 | -4.52 Mn |
| Mar 31, 2023 | -5.01 Mn |
| Dec 31, 2022 | -6.06 Mn |
| Sep 30, 2022 | -5.41 Mn |
| Jun 30, 2022 | -6.96 Mn |
| Mar 31, 2022 | -6.64 Mn |
| Dec 31, 2021 | 8.71 Mn |
| Sep 30, 2021 | -5.50 Mn |
| Jun 30, 2021 | -4.06 Mn |